Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming.

Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Abstract Text:

    hui ling chenHui Ling Chen,tao liTao Li,xin wen qiuXin Wen Qiu,jie wuJie Wu,jian qun lingJian Qun Ling,zhi hong sunZhi Hong Sun,weibo wangWeibo Wang,wei chenWei Chen,aiju houAiju Hou,thanh h vuThanh H Vu,andrew r hoffmanAndrew R Hoffman,ji-fan huJi-Fan Hu,

    Loss of genomic imprinting of insulin-like growth factor II (IGF2) is a hallmark of many human neoplasms. We attempted to correct this aberrant epigenotype by transferring nuclei from human tumor cells that showed loss of IGF2 imprinting into enucleated mouse and human fibroblasts that had maintained normal IGF2 imprinting. After nuclear transfer, the abnormal biallelic expression of IGF2 in tumor nuclei transiently converted to normal monoallelic imprinted expression in the reconstructed diploid cells. In tetraploid hybrid cells, however, normal IGF2 imprinting was permanently restored in the tumor genome. Inhibition of the synthesis of putative trans imprinting factors with cycloheximide led to loss of IGF2 imprinting in normal cultured fibroblasts, suggesting that normal cells produce proteins that act in trans to induce or maintain genomic imprinting. These data demonstrate that an abnormal tumor epigenotype can be corrected by in vitro reprogramming, and suggest that loss of imprinting is associated with the loss of activity of non-CTCF trans imprinting factor(s) that are either inactivated or mutated in tumors.

    Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Publishing Authors By Initials

    hl chenHL Chen,t liT Li,xw qiuXW Qiu,j wuJ Wu,jq lingJQ Ling,zh sunZH Sun,w wangW Wang,w chenW Chen,a houA Hou,th vuTH Vu,ar hoffmanAR Hoffman,jf huJF Hu,

    For similar proteins: transcription factors: repressor proteins research abstracts see: proteins: transcription factors: repressor proteins research

    PUBMED ID PMID:

    MEDLINE DATE:

    Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: The EMBO journal

    VOLUME: 25

    Page Numbers: 5329-38

    Journal Abbreviation: EMBO J.

    ISSN: 0261-4189

    DAY: 2

    MONTH: 11

    YEAR: 2006

    Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8208664

    Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Keywords Mesh Terms:

    KEYWORDS: Repressor Proteins

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Information

    Substance Name: Insulin-Like Growth Factor II

    Registry Number: 67763-97-7

    Grant and Affiliation Information for Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming.

    AFFILIATION: Medical Service, VA Palo Alto Health Care System, Palo Alto, CA, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: R43 CA86664-01

    ACRONYM: CA

    MEDLINETA: EMBO J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News